Metraipolis › archive › dc_f8adbf64387d

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial — Europe PMC PMID:42577288

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42577288
DOI: 10.1016/j.lanepe.2026.101721
License (as archived): solo-consultazione
Archived: 2026-10-31T22:53:18.510Z
SHA-256 of the archived text: c7de7c8c5f2ea50193b39fc86dda3e32ed85e25a1466293e8bbc5ad57414959e
Stable URL of this page: https://metraipolis.com/documento/dc_f8adbf64387d

How to cite

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial — Europe PMC PMID:42577288 — Europe PMC (en), https://europepmc.org/article/MED/42577288 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f8adbf64387d (Metraipolis archive dc_f8adbf64387d, sha256 c7de7c8c5f2ea50193b39fc86dda3e32ed85e25a1466293e8bbc5ad57414959e)

BibTeX

@misc{dcf8adbf64387d,
  title = {Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial — Europe PMC PMID:42577288},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42577288},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f8adbf64387d; sha256 c7de7c8c5f2ea50193b39fc86dda3e32ed85e25a1466293e8bbc5ad57414959e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42577288. Agents can read the archived copy with the MCP tool read_document.